Your browser doesn't support javascript.
loading
Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice.
Buchler, Tomas; Kiss, Igor; Hornova, Jana; Fiala, Ondrej; Wiesnerova, Marketa; Svoboda, Michal; Silar, Jiri; Kopeckova, Katerina; Poprach, Alexandr; Finek, Jindrich; Petruzelka, Lubos; Melichar, Bohuslav.
Affiliation
  • Buchler T; Department of Oncology, First Faculty of Medicine, Charles University, Thomayer University Hospital, Videnska 800, 140 59, Prague, Czech Republic. tomas.buchler@ftn.cz.
  • Kiss I; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty Kopec 543/7, 656 53, Brno, Czech Republic.
  • Hornova J; Department of Oncology, First Faculty of Medicine, Charles University, Thomayer University Hospital, Videnska 800, 140 59, Prague, Czech Republic.
  • Fiala O; Department of Oncology and Radiotherapeutics, University Hospital in Pilsen, Alej Svobody 80, 304 60, Pilsen, Czech Republic.
  • Wiesnerova M; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 76, 323 00, Pilsen, Czech Republic.
  • Svoboda M; Institute of Biostatistics and Analyses, Postovská 68/3, 602 00, Brno, Czech Republic.
  • Silar J; Institute of Biostatistics and Analyses, Postovská 68/3, 602 00, Brno, Czech Republic.
  • Kopeckova K; Institute of Biostatistics and Analyses, Postovská 68/3, 602 00, Brno, Czech Republic.
  • Poprach A; Department of Oncology, Motol University Hospital, Second Faculty of Medicine, Charles University, V Uvalu 84, 150 00, Prague, Czech Republic.
  • Finek J; Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty Kopec 543/7, 656 53, Brno, Czech Republic.
  • Petruzelka L; Department of Oncology and Radiotherapeutics, University Hospital in Pilsen, Alej Svobody 80, 304 60, Pilsen, Czech Republic.
  • Melichar B; Department of Oncology, General University Hospital, Charles University First Faculty of Medicine, U Nemocnice 499/2, 128 08, Prague, Czech Republic.
Target Oncol ; 15(2): 193-201, 2020 04.
Article in En | MEDLINE | ID: mdl-32052341
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Vascular Endothelial Growth Factor / Bevacizumab Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Czech Republic
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Vascular Endothelial Growth Factor / Bevacizumab Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Target Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Czech Republic